Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hyperaldosteronism × Endocrine × Clear all

Phase

Phase NA 5 Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 29 Multiple Endocrine Neoplasia Type 1 9 Neoplasms 7 Pituitary ACTH Hypersecretion 6 Carcinoid Tumor 6 Pheochromocytoma 5 Gastro-enteropancreatic neuroendocrine tumor 5 Adrenocortical Carcinoma 5 Thyroid Neoplasms 4 Thyroid Cancer, Papillary 4 Serotonin Syndrome 4 Pituitary Neoplasms 4 Pituitary Diseases 4 Neuroblastoma 4 Differentiated Thyroid Cancer 4 Cushing Syndrome 4 Breast Neoplasms 4 ACTH Syndrome, Ectopic 4 Sarcoma 3 Liposarcoma 3 Insulinoma 3 Fibrosarcoma 3 Endometrial Neoplasms 3 Carcinoma, Medullary 3 Adenoma, Islet Cell 3 Sarcoma, Synovial 2 Sarcoma, Endometrial Stromal 2 Parkinson Disease 2 Paraganglioma 2 Ovarian Neoplasms 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01096654 2015-07-16

SPARTACUS

Radboud University Medical Center

Phase 3 Completed

Hyperaldosteronism, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡